I am deeply aware of the heretical enterprise that I am venturing on, or even of the risk of causing stress in some readers by the first two words ofmy title. It might deserve to be called a contemptuous misnomer were it not to be used in the United Kingdom, the respected motherland of all the basic achievements in the field of that utterly bad condition called asbestosis. Nevertheless, with all due respect towards British occupational medicine, and the country which long ago directed my first steps in that branch ofmedicine, I dare to propose and use the term "benign asbestosis," bearing in mind all the dissent and resistance, and also all the advantages, of its possible laissez-passer.
There are several reasons for this notion but the most important is the irrefutable fact that many cases-perhaps up to 80% or more-of "asbestos related diseases" do have a benign course and this alone would be a sufficiently good reason to call them benign asbestosis. To refer to the common pleural affections, the circumlocution asbestos related diseases was coined apparently to avoid even the slightest connotation ofthe ghastly pneumoconiosis asbestosis, although the term does not sound more euphemistic than "tubercle bacillus related disease" might have done had it been used instead of "tuberculosis." Yet, since the term may also encompass the neoplastic manifestations, it was necessary to add to the common pleural manifestations the reassuring adjective "benign" and thus the poor syntagma "benign asbestos related disease of the pleura" was born, instead of allowing the term "pleural asbestosis" to come into use as one of the most typical examples of benign asbestosis.
The crucial issue, however, has not been one of semantics. Thoughts on asbestosis have changed as asbestosis itself has been changing its clinical, epidemiological, and, particularly, its prognostic pattern. This changing pattern is repeatedly calling for some revision of our attitude but also for our compliance. For example, in a recent paper, for a diagnosis of asbestosis "at least two of the following criteria: (i) pathological chest radiograph-that is, 1/0 or more, (ii) findings in the lung physiology in agreement with fibrosis, or (iii) inspiratory rales on auscultation" were required.3 The diagnosis ofasbestosis could be established whichever of the two criteria were present. Seven of the 24 thoroughly examined subjects from a large group presented in the paper were lucky enough to have met only one of the three criteria; having only a "profusion 1/0 or more [of irregular small opacities]; no diagnosis of asbestosis was made" and there was, therefore, no need for them to change their jobs. Had they also had, for example, inspiratory rales on auscultation, however, they would have had the 434 misfortune to attract a diagnosis of asbestosis, but obviously "not the same as seen by old authors," but still with all the medicolegal consequences or rights that might arise from the certified disease. This by no means implies that one should question or deprecate the validity of this or any other set ofcriteria that have been offered from time to time during the past decade. On the contrary, they could undoubtedly be of great help in ascertaining those initial or early, mild or discrete manifestations of asbestosis whose presence might be questioned but whose existence cannot be denied.
Another mosaic of thoughts. The life long persistence of (calcified) pleural plaques found in thousands of people in many endemic areas is indisputably a reliable biological sign and strong evidence of long lasting exposure to asbestos, both manmade and natural. Pleural plaques-as Becklake4 would sayhave been dubbed the visiting cards of asbestos. Interestingly enough, however, in the great majority of affected people there seems to be no gross morbidity and no registered mortality from (pulmonary) asbestosis. Nevertheless, are we absolutely sure that discrete non-progressive changes do not occur? Would it not be hard to believe that asbestos fibres, as they travel through the lung parenchyma to reach the pleura, cause the damage to pleura but do not at the same time do any harm to the parenchyma? Are they really so carefully ferried by the macrophages that they are kept only to appear finally at the parietal pleural layer 'even in the absence ofadhesions"?5 Or, perhaps, they do not travel via the parenchyma at all?
Further information might give the natural course of asbestosis. As in many other human fibroblastic diseases it apparently depends on the unpredictable behaviour of the fibroblasts. Their inactivity, their activity, or their overactivity is reflected in corresponding degrees of the progression that directs the sequence of events and the outcome of asbestosis. The fate of the patient is thus governed by the dynamics of progression and it is the progression itself that has become the main feature and the main hazard of asbestosis.
Discussing the development and progression of asbestosis in his classic work on occupational lung disorders, Parkes states that "among men with similar exposure some subsequently have severe asbestosis, some mild and others apparently none."6 Moreover, 'in some cases the disease is apparently arrested and no further progression occurs." It might be noteworthy that such experience stems from the time of heavy exposures. Similar data are given subsequently. Gregor et al showed that 30 of 39 cases (77%) with a radiographic category greater than 1/1, followed up for a minimum of three and up to seven years, showed no progression.7 "Even within the group of patients who had severe asbestosis (2/2 and greater) and who were followed over this time, the majority (13/16) displayed no progression." In a nine year follow up study of men who were heavily exposed before 1966 Sheers found (only) six deaths directly attributable to pulmonary fibrosis in a total of 36 cases. 8 In other human fibrosing disorders we have been trying to learn how to maintain the inactivity of the fibroblasts, how to suppress their activity, or how to fight their overactivity.
In asbestosis we know much about the mortality, we know that-at present-every fifth man may die of carcinoma of the lung, and we know that some will die of mesothelioma even after relatively low exposure to asbestos. We know little, however, about the great majority ofthose who survive and who might enjoy life without fear and who have the right to know that they have non-progressive asbestosis; whose ailment may therefore, despite all dissent be simply called benign asbestosis at least so long as they show no signs of progression.
We can have no doubts that asbestos may cause severe disease with much disability and none about its carcinogenicity, but we should not sentence people with asbestosis of any "profusion scores" or in any location to life long fear. The word asbestosis has to be deprived of its macabre meaning and its grim implications since we cannot ignore those millions and millions of people who retain asbestos bodies in their lungs as evidence of the action of asbestos (not of the mere presence of fibres) or those thousands and thousands of people with pleural fibrosis as evidence of benign asbestos disease (not merely the sign of exposure).
One might disregard the thoughts but not ignore the facts! The rest is research.
